Clinical Trial Update: Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana [Phase 4]

View source ↗

Summary

PATH's Phase 4 trial of mebendazole for hookworm infections in children and adolescents in Ghana has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hookworm Infections

Drugs mentioned

• Mebendazole (Mebendazole)

Snippet

Sponsor: PATH | Conditions: Hookworm Infections | Phase 4 | Status: WITHDRAWN